About 1,821,681 results (4,752 milliseconds)

WO1992019261A1 - Use of vasoactive intestinal peptide (vip) to ...

https://patents.google.com/patent/WO1992019261A1/en
A method of inducing a temporary substantial paralysis of an area of interest in a patient undergoing a medical procedure is provided.

WO2016114655A1 - Treating neuromuscular or neurologic disease ...

https://patents.google.com/patent/WO2016114655A1/en
Methods for treating one or more symptoms caused by inhibitory neurotransmitter overstimulation (e.g., muscle wasting, loss of muscle function, loss of muscle ...

EP3242893A1 - Lingo-1 antagonists and uses for treatment of ...

https://patents.google.com/patent/EP3242893A1/en
Thus, methods, compositions and kits described herein can be useful for treating a CNS disorder, e.g., a CNS demyelinating disease. In one aspect, the invention ...

WO2011057199A1 - Compositions for treating cns disorders ...

https://patents.google.com/patent/WO2011057199A1/en
The level of breakdown can have profound effects on the clinical outcome of these diseases. ... Gabapentin (Neurontin®) 100-800 mg tablets. Hydroxyzine 10 ...

US20030178031A1 - Method for cancer pain treatment - Google ...

https://patents.google.com/patent/US20030178031A1/en
Instruct the patient to monitor for early side effects that will likely only be transient ... Failure to do so can result in patient medullary paralysis ...

US20090156982A1 - Transdermal treatment device and method ...

https://patents.google.com/patent/US20090156982A1/en
It lacks the danger of injections, and does not cause embarrassment of suppository application or discomfort of a nose drop or spray. It may also prevent “ ...

CN102341380A - Bumetanide, furosemide, piretanide, azosemide ...

https://patents.google.com/patent/CN102341380A/en
Antidepressants can cause slight and typically temporary side effect in some, but they are not usually long-term.The most common side effect related with SNRIs ...

WO2012018635A2 - Arylsulfonamide derivatives, compositions, and ...

https://patents.google.com/patent/WO2012018635A2/un
Antidepressants may cause mild and often temporary side effects in some ... Tricyclic antidepressants also can cause side effects including: dry mouth ...

KR101202240B1 - Substituted acylanilides and methods of use ...

https://patents.google.com/patent/KR101202240B1/en
Neglecting muscle exhaustion can cause serious health problems. For example, changes that occur during muscle wasting can lead to a weakening of the ...

WO2011011528A1 - Isopropylphenidate for the treatment of ...

https://patents.google.com/patent/WO2011011528A1/en
Some forms of epilepsy can also cause ADHD like behaviour which can be misdiagnosed as ADHD. ... Sleep paralysis is the temporary inability to talk or move ...

CN102470160A - Compounds which inhibit muscle contraction ...

https://patents.google.com/patent/CN102470160A/en
Botulic neurotoxin causes muscular paralysis and even can be because heartbeat stops and causes death. ... temporary or permanent protection base, and can ...

US20170246131A1 - Bumetanide analogs, compositions, and ...

https://patents.google.com/patent/US20170246131A1/en
Transient insomnia lasts from days to weeks. It can be caused by another disorder, by changes in the sleep environment, by the timing of sleep, severe ...

CA2721927C - Auris formulations for treating otic diseases and ...

https://patents.google.com/patent/CA2721927C/en
1C1N-017physical injury to the inner ear organ. in some eases., no cause can be identified. Tinnitus and vertigo may accompany sudden deafness, which subsides ...

MX2011007759A - Bumetanide, furosemide, piretanide, azosemide ...

https://patents.google.com/patent/MX2011007759A/en
Antidepressants can cause mild and often temporary side effects in some ... The present invention can also be performed in patients animal, patients ...

EP2389371A2 - Bumetanide, furosemide, piretanide, azosemide ...

https://patents.google.com/patent/EP2389371A2/en
Transient insomnia lasts from days to weeks. It can be caused by another disorder, by changes in the sleep environment, by the timing of sleep, severe ...

US9682928B2 - Bumetanide analogs, compositions and methods of ...

https://patents.google.com/patent/US9682928B2/en
Transient insomnia lasts from days to weeks. It can be caused by another disorder, by changes in the sleep environment, by the timing of sleep, severe ...

WO2009085226A2 - Inhibitors of cdc2-like kinases (clks) and ...

https://patents.google.com/patent/WO2009085226A2/en
The compositions and methods so described would be useful for treatment of diseases that have as a cause excessive kinase activity leading to abnormal splicing, ...

WO2009089011A2 - Resveratrol formulations - Google Patents

https://patents.google.com/patent/WO2009089011A2/en
Cell death can also be caused by surgery, drug therapy, chemical exposure or radiation exposure. Formulation of the inventions can also be administered to a ...

US20120004225A1 - Bumetanide, furosemide, piretanide ...

https://patents.google.com/patent/US20120004225A1/en
For all classes of antidepressants, patients can experience side effects. Antidepressants may cause mild and often temporary side effects in some people, but ...

CA2554089C - Albumin fusion proteins - Google Patents

https://patents.google.com/patent/CA2554089C/en
blood vessels; inhibits plasma Prostaglandin E2 synthesis can be determined Renal Glomerular disease. renin activity; causes diuresis using assays known in the ...